Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer

被引：0
|
作者：
Laura Mezquita
Marianne Oulhen
Agathe Aberlenc
Marc Deloger
Mihaela Aldea
Aurélie Honore
Yann Lecluse
Karen Howarth
Luc Friboulet
Benjamin Besse
David Planchard
Françoise Farace
机构：
[1] Gustave Roussy,
[2] Université Paris-Saclay,undefined
[3] Department of Medicine,undefined
[4] Medical Oncology Department,undefined
[5] Hospital Clinic of Barcelona,undefined
[6] Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors,undefined
[7] IDIBAPS,undefined
[8] Gustave Roussy,undefined
[9] Université Paris-Saclay,undefined
[10] “Rare Circulating Cells” Translational Platform,undefined
[11] CNRS UMS3655—INSERM US23 AMMICA,undefined
[12] INSERM,undefined
[13] U981 “Identification of Molecular Predictors and new Targets for Cancer Treatment”,undefined
[14] Gustave Roussy,undefined
[15] Université Paris-Saclay,undefined
[16] Bioinformatics Platform,undefined
[17] CNRS UMS3655—INSERM US23 AMMICA,undefined
[18] Gustave Roussy,undefined
[19] Université Paris-Saclay,undefined
[20] Genomic Platform,undefined
[21] CNRS UMS3655—INSERM US23 AMMICA,undefined
[22] Gustave Roussy,undefined
[23] Université Paris-Saclay,undefined
[24] “Flow cytometry and Imaging” Platform,undefined
[25] CNRS UMS3655—INSERM US23AMMICA,undefined
[26] Inivata Ltd,undefined
[27] Babraham Research Park,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：682 / 693
页数：11
相关论文
共 50 条
  • [41] Clinician Perspective on Molecular Profiling of Non-Small-Cell Lung Cancer
    Decatris, Marios P.
    Farrugia, David
    O'Byrne, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 884 - +
  • [42] Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF plus Non-Small Cell Lung Cancer
    Ortiz-Cuaran, S.
    Mezquita, L.
    Swalduz, A.
    Aldea, M.
    Mazieres, J.
    Jovelet, C.
    Flores, W. R. Chumbi
    Lacroix, L.
    Loriot, Y.
    Friboulet, L.
    Westeel, V.
    Ngocamus, M.
    Pradines, A.
    Tissot, C.
    Duchene, C. Clement
    Raynaud, C.
    Quantin, X.
    Gervais, R.
    Brain, E.
    Monnet, I.
    Leprieur, E. Giroux
    Avrillon, V.
    Oukhatar, C. Mahier-Ait
    Hoog-Labouret, N.
    De Kievit, F.
    Howarth, K.
    Guichou, J.
    Morris, C.
    Green, E.
    Perol, M.
    Besse, B.
    Blay, J.
    Saintigny, P.
    Planchard, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S337 - S337
  • [43] BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
    Li, Ming
    Zhang, Xiaoying
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (02) : 110 - 111
  • [44] BRAF-mutations in non-small cell lung cancer
    Brustugun, Odd Terje
    Khattak, Asma Malik
    Tromborg, Anette Kjoshagen
    Beigi, Marzieh
    Beiske, Klaus
    Lund-Iversen, Marius
    Helland, Aslaug
    LUNG CANCER, 2014, 84 (01) : 36 - 38
  • [45] Targeting BRAF mutations in non-small cell lung cancer
    O'Leary, Connor Gerard
    Andelkovic, Vladamir
    Ladwa, Rahul
    Pavlakis, Nick
    Zhou, Caicun
    Hirsch, Fred
    Richard, Derek
    O'Byrne, Kenneth
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1119 - 1124
  • [46] BRAF inhibitors in metastatic non-small cell lung cancer
    Anguera, Georgia
    Majem, Margarita
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 589 - 592
  • [47] Cutaneous Metastasis as the First Presentation of Non-Small-Cell Lung Cancer with a BRAF Mutation: A Case Report
    Wang, Xuejun
    Wang, Hongmei
    Jia, Baochang
    He, Fang
    Yuan, Yawei
    Zhang, Weijun
    ONCOTARGETS AND THERAPY, 2020, 13 : 13143 - 13149
  • [48] BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practice
    Parisi, Claudia
    Planchard, David
    CANCER, 2025, 131
  • [49] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [50] Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition
    Maniar, Rohan
    Gallitano, Stephanie M.
    Husain, Sameera
    Moazami, Golnaz
    Weiss, Michael J.
    Shu, Catherine A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (03): : 232 - 234
12345